Home
Search:
1146 feeds
357 categories
5703 articles (<24 hours)
14 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve


Valid HTML 4.01 Transitional

RSS FeedsDEP irinotecan combination outperforms in refractory human colon cancer model
(WorldNews Business)

 
 

24 may 2019 03:03:35

 
DEP irinotecan combination outperforms in refractory human colon cancer model
(WorldNews Business)
 




DEP® irinotecan combination outperforms in refractory human colon cancer model DEP® irinotecan, a proprietary nanoparticle formulation, in combination with cetuximab (Erbitux®) showed complete suppression of tumour growth and 100% survival in an irinotecan-refractory human colon cancer model The significant antitumor effect induced by DEP® irinotecan was despite the fact that leading colon cancer treatments, irinotecan (Camptosar®) and Erbitux®, showed limited activity in this human colon cancer model This study builds on previously announced promising efficacy data for DEP® irinotecan in human colon and pancreatic cancer models Starpharma is currently completing final trial preparations for...
 
8 viewsCategory: Business
 
TCU scores 14 in 4th inning, blasts Oklahoma 15-3
(WorldNews Business)
Material Fact - Issuance of Debenture
(WorldNews Business)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2019 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn